Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidoderm fMRI in Chronic Back Pain
NCT01515540Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Jan 2004
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in chronic low back pain (CLBP) (2 arms), sponsored by Northwestern University. Primary endpoint: Visual Analog Scale at 2 weeks. Started Jan 2004; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01515540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01515540.